Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Abstract Background: Cannabidiol (CBD) is a major chemical compound present in Cannabis sativa. CBD is a nonpsychotomimetic substance, and it…
Abstract Background: Cannabidiol (CBD) is a major chemical compound present in Cannabis sativa. CBD is a nonpsychotomimetic substance, and it…
Abstract The first treatments showing effectiveness for some psychiatric disorders, such as lithium for bipolar disorder and chlorpromazine for schizophrenia,…
Abstract Background: There is a lack of published guidelines related to the use of complementary and alternative medicine (CAM) for…
Abstract Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested…
Abstract Drugs of abuse are associated with stroke, especially in young individuals. The major classes of drugs linked to stroke…
Abstract Effective treatments for pain management remain elusive due to the dangerous side-effects of current gold-standard opioid analgesics, including the…
Abstract Lifestyle is a well-known environmental factor that plays a major role in facilitating the development of metabolic syndrome or…
Abstract Given the rise in teenage use of electronic nicotine delivery systems (“vaping”) in congruence with the increasing numbers of…
Abstract Purpose of Review: Chemotherapy-induced nausea and vomiting (CINV) is a common cause of acute morbidity that impacts quality of…
Abstract Cannabis products (marijuana, weed, hashish) are among the most widely abused psychoactive drugs in the world, due to their…